The metabolism of a typical type-I substrate, aminopyrine (58151), by microsomes prepared from the skin of neonatal rats was reported. Skin microsomes were prepared from Sprague-Dawley-rats on day four after birth. The neonatal rat skin microsomes were incubated with carbon-14 labeled aminopyrine for 20 minutes, and then the quantity of formaldehyde formed was determined. The presence of aminopyrine- N-demethylase activity in the microsomes was demonstrated. The drug metabolizing enzyme activity was NADPH dependent. Activity in the presence of NADH alone was only 37 percent that of NADPH. Addition of NADH to incubation mixtures containing NADPH resulted in an 8 percent increase in formaldehyde formation. No formaldehyde formation was noted when either boiled enzyme was used in the complete incubation system or when the pyridine nucleotide or the regenerating system was omitted from the incubation mixture. Cofactor requirements for neonatal skin aminopyrine-N-demethylation closely resembled those of the hepatic N-demethylase. Under the conditions of this aminopyrine-N-demethylase assay, formaldehyde formation by neonatal rat skin microsomes was directly proportional to the amount of microsomal protein employed and to the time of incubation. The data indicated that skin does contain aminopyrine-N- demethylase activity and that skin microsomes are active in metabolizing a type-I substrate such as aminopyrine. These data emphasized that the small amount of measurable-P-450 in skin microsomes is capable of considerable metabolism of appropriate substrates.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.